人类乳头状瘤病毒31 E7抗体
VE7_HPV31; Protein E7; E7; Human Papilloma Virus; Human papillomavirus type 31 E7; Human papillomavirus type 31 (E7); Human papillomavirus type 31 E7; Human papillomavirus type 31 E7 protein; Protein
轴丝动力蛋白2抗体
axonemal; Axonemal beta dynein heavy chain 2; Ciliary dynein heavy chain 2; Dnah2; DYH2_HUMAN; Dynein heavy chain 2; Dynein heavy chain domain-containing protein 3.
P53诱导细胞凋亡抑制蛋白抗体
Inhibitor of p53 induced apoptosis beta; IPIA beta; NDK-H 5; NDP kinase homolog 5; NM23 H5; Nm23-M5; NM23H5; Non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase); Nonmetastatic
肌微管素相关蛋白11抗体
Cisplatin resistance-associated protein; CRA; hCRA; Mtmr11; MTMRB_HUMAN; Myotubularin-related protein 11.
微小染色体维持缺陷蛋白8抗体
C20orf154; dJ967N21.5; DNA helicase MCM8; DNA replication licensing factor MCM8; MCM8; MCM8_HUMAN; MGC119522; MGC119523; MGC12866; MGC4816; Minichromosome maintenance 8; Minichromosome main
Anti-MYOZ2 Polyclonal Antibody
Anti-MYOZ2 Polyclonal Antibody应用 WB 稀释比例 WB 1:5000-8000. 交叉反应 Human
Anti-AFP Polyclonal Antibody
Anti-AFP Polyclonal Antibody 应用 IHC 稀释比例 IHC 1:25-100. 交叉反应 Human